HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Jin Selected Research

fibroblast activation protein alpha

9/2005'Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer'.
9/2003Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer.
7/2003Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm.
1/2003Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Jin Research Topics

Disease

181Neoplasms (Cancer)
06/2022 - 01/2003
35Neoplasm Metastasis (Metastasis)
02/2022 - 01/2003
31Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 01/2017
30Inflammation (Inflammations)
05/2022 - 02/2010
22Hepatocellular Carcinoma (Hepatoma)
01/2022 - 09/2009
20Infections
06/2022 - 06/2007
19Lung Neoplasms (Lung Cancer)
01/2022 - 07/2012
18Hypoxia (Hypoxemia)
01/2022 - 05/2010
17Atherosclerosis
10/2021 - 08/2003
14Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2003
14Insulin Resistance
01/2021 - 08/2008
13Breast Neoplasms (Breast Cancer)
06/2022 - 02/2014
13Glioma (Gliomas)
01/2022 - 02/2010
12Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 08/2012
11Carcinogenesis
01/2022 - 09/2017
11Body Weight (Weight, Body)
01/2022 - 05/2012
11Carcinoma (Carcinomatosis)
02/2020 - 07/2003
10Lymphatic Metastasis
03/2018 - 01/2003
9COVID-19
01/2022 - 01/2020
9Ischemia
12/2021 - 06/2007
9Wounds and Injuries (Trauma)
12/2021 - 10/2012
9Adenocarcinoma
11/2020 - 01/2003
8Squamous Cell Carcinoma of Head and Neck
08/2022 - 01/2014
8Cognitive Dysfunction
05/2022 - 04/2015
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2012
8Myocardial Infarction
01/2022 - 05/2008
8Osteosarcoma (Osteogenic Sarcoma)
10/2021 - 02/2017
7Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2016
7Hypertension (High Blood Pressure)
01/2022 - 11/2011
7Brain Ischemia (Cerebral Ischemia)
01/2019 - 01/2006
6Necrosis
08/2022 - 07/2010
6Mitochondrial Diseases (Mitochondrial Disease)
08/2022 - 01/2013
6Glioblastoma (Glioblastoma Multiforme)
01/2021 - 12/2016
6Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 09/2003
6Pain (Aches)
01/2019 - 01/2012
6Parkinson Disease (Parkinson's Disease)
01/2019 - 01/2009
6Nasopharyngeal Carcinoma
05/2018 - 10/2004
5Fibrosis (Cirrhosis)
02/2022 - 01/2014
5Sepsis (Septicemia)
01/2022 - 10/2015
5Neuroinflammatory Diseases
01/2022 - 01/2019
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2016
5Reperfusion Injury
10/2021 - 06/2007
5Leukemia
09/2021 - 01/2018
5Adenocarcinoma of Lung
08/2021 - 01/2018
5Diabetic Retinopathy (Retinopathy, Diabetic)
06/2021 - 10/2014
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 02/2012
5Hyperlipidemias (Hyperlipidemia)
01/2021 - 06/2009
5Ischemic Stroke
01/2021 - 12/2013

Drug/Important Bio-Agent (IBA)

83Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2003
33Pharmaceutical PreparationsIBA
01/2022 - 02/2010
30Biological ProductsIBA
03/2022 - 01/2003
27Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
23Long Noncoding RNAIBA
08/2022 - 04/2017
23Messenger RNA (mRNA)IBA
01/2022 - 06/2007
19MicroRNAs (MicroRNA)IBA
01/2022 - 12/2016
18Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2011
14Therapeutic UsesIBA
01/2022 - 09/2009
14LipidsIBA
11/2021 - 08/2008
14EnzymesIBA
01/2021 - 12/2009
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 06/2007
12RNA (Ribonucleic Acid)IBA
01/2022 - 01/2014
11Transcription Factors (Transcription Factor)IBA
02/2022 - 11/2007
11CytokinesIBA
01/2022 - 07/2010
11Reactive Oxygen Species (Oxygen Radicals)IBA
07/2020 - 06/2007
10Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 03/2015
9Circular RNAIBA
01/2022 - 04/2017
8HydrogelsIBA
01/2022 - 04/2018
8LipopolysaccharidesIBA
01/2022 - 07/2016
8Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 04/2013
8oleoylethanolamideIBA
01/2020 - 04/2015
8MicellesIBA
11/2019 - 12/2016
7InflammasomesIBA
08/2022 - 01/2019
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2010
7Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 11/2013
7GemcitabineFDA Link
01/2021 - 01/2017
7Cisplatin (Platino)FDA LinkGeneric
12/2020 - 09/2003
6Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2022 - 01/2017
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2012
6Indicators and Reagents (Reagents)IBA
01/2022 - 12/2015
6InterleukinsIBA
01/2022 - 07/2010
6Blood Glucose (Blood Sugar)IBA
10/2021 - 11/2008
6LigandsIBA
09/2021 - 01/2017
6Oxygen (Dioxygen)IBA
01/2021 - 12/2015
6Liposomes (Liposome)IBA
01/2020 - 01/2017
6ElementsIBA
11/2018 - 06/2006
6IronIBA
10/2018 - 06/2016
6Insulin (Novolin)FDA Link
01/2018 - 11/2008
5Immune Checkpoint InhibitorsIBA
01/2022 - 02/2019
5Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2017
5ChitosanIBA
08/2021 - 04/2018
5Retinaldehyde (Retinal)IBA
06/2021 - 10/2014
5Adenosine Triphosphate (ATP)IBA
01/2021 - 06/2015
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 05/2017
5B7-H1 AntigenIBA
11/2020 - 11/2018
5FlavonoidsIBA
01/2020 - 01/2011

Therapy/Procedure

67Therapeutics
01/2022 - 05/2008
19Drug Therapy (Chemotherapy)
01/2022 - 02/2010
10Immunotherapy
01/2022 - 11/2018
8Radiotherapy
05/2022 - 02/2010
5Injections
01/2022 - 01/2017